Pfizer Inc.
IL-15 Variants and Uses Thereof

Last updated:

Abstract:

The present invention relates to human interleukin 15 (IL-15) variants that have therapeutic and diagnostic use, and methods for making thereof. The present invention also provides fusion proteins comprising a human IL-15 variant. Also provided are methods of stimulating or suppressing immune responses in a mammal, and methods of treating a disorder (e.g., cancer) using the IL-15 variants or the fusion protein of such IL-15 variants.

Status:
Application
Type:

Utility

Filling date:

24 Jun 2021

Issue date:

21 Oct 2021